Search results

74 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Is the finger-stick blood test necessary for type 2 diabetes treatment?
In the first large pragmatic trial of its kind in the United States, results from a UNC School of Medicine study show that checking finger-stick blood sugars may not help diabetes patients who do not use insulin.
Located in News / 2017 / June
UNC co-leads large clinical trial on new combo therapy for type 2 diabetes
New insulin degludec has comparable cardiovascular safety rates to insulin glargine U100 but with less risk of triggering low blood sugar.
Located in News / 2017 / June
UNC/NC State spinout company raises $5.8M for ‘smart’ insulin devices
A Research Triangle Park startup founded by Zhen Gu, PhD, a biomedical engineer with joint faculty appointments at UNC and NC State University received a $5.8 million cash infusion to continue translation efforts of ‘smart’ insulin devices.
Located in News / 2017 / June
Smart Artificial Beta Cells Could Lead to New Diabetes Treatment
In lab experiments and animal models, UNC and NC State researchers led by Zhen Gu, PhD, designed synthetic beta cells to secrete insulin in response to high blood sugar.
Located in News / 2017 / October
Buse leads clinical trial of new type 1 diabetes treatment
The study is designed to evaluate whether TTP399 is well tolerated when administered as an add-on to insulin therapy and can improve daily glucose profiles and HbA1c in people living with type 1 diabetes.
Located in News / 2017 / November
Kirkman to chair National Diabetes Education Program
M. Sue Kirkman, MD, Professor of Medicine and Medical Director of the UNC Diabetes Care Center's Clinical Trials Unit, has been appointed Chair of the National Diabetes Education Program. Kirkman's term as Chair begins on Jan. 1, 2018.
Located in News / 2017 / December
UNC School of Medicine researcher receives American Diabetes Association award
Praveen Sethupathy, PhD, earns early-career ADA award to research innovative ways to treat people with diabetes.
Located in News / 2016 / February
Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship
The joint UNC/NC State researcher also earned a grant from JDRF and Sanofi to further develop glucose responsive insulin therapies for diabetes.
Located in News / 2016 / February
New type-2 diabetes therapy proves better than traditional insulin injections
UNC-led global phase-3 clinical trial sets the stage for improved management of a disease that affects nearly 30 million Americans.
Located in News / 2016 / March
Scientists create painless patch of insulin-producing beta cells to control diabetes
The new “smart cell patch” developed at UNC and NC State is a proof of principle to treat millions of people with type-1 and advanced type-2 diabetes.
Located in News / 2016 / March